Gilead Sciences, Inc. GILD | NASDAQ
Next Earnings: Jul 26, 2026
Company Overview:
10 Year GILD Performance Metrics:
GILD Dividend Payments, Yield & Share Price charts
Unlock All Reports & Research Dividend Stocks.
[lev_ptables no_sale]GILD Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.
GILD Earnings, Revenue, Cash & Debt, Shares Outstaning:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
GILD Dividends Info:
GILD Dividend History: Dates, Payments & Yield list
Below is a schedule of all GILD dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield
| Ex-Date | Payment Date | Amount | TTM Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 06/15/2026 | 06/29/2026 | $0.820 | 2.59% | 2.6% | $126.33 |
| 03/13/2026 | 03/30/2026 | $0.820 | 2.2% | 2.41% | $136.34 |
| 12/15/2025 | 12/30/2025 | $0.790 | 2.64% | 2.57% | $123.18 |
| 09/15/2025 | 09/29/2025 | $0.790 | 2.79% | 2.81% | $112.62 |
| 06/13/2025 | 06/27/2025 | $0.790 | 2.84% | 2.86% | $110.67 |
| 03/14/2025 | 03/28/2025 | $0.790 | 2.78% | 2.83% | $111.79 |
| 12/13/2024 | 12/30/2024 | $0.770 | 3.35% | 3.35% | $92.01 |
| 09/13/2024 | 09/27/2024 | $0.770 | 3.7% | 3.68% | $83.61 |
| 06/14/2024 | 06/27/2024 | $0.770 | 4.67% | 4.47% | $68.83 |
| 03/14/2024 | 03/28/2024 | $0.770 | 4.07% | 4.2% | $73.25 |
| 12/14/2023 | 12/28/2023 | $0.750 | 3.67% | 3.7% | $81.14 |
| 09/14/2023 | 09/28/2023 | $0.750 | 3.85% | 3.98% | $75.42 |
| 06/14/2023 | 06/29/2023 | $0.750 | 3.8% | 3.95% | $76.01 |
| 03/14/2023 | 03/30/2023 | $0.750 | 2.77% | 3.68% | $81.45 |
| 12/14/2022 | 12/29/2022 | $0.730 | 3.3% | 3.42% | $85.26 |
| 09/14/2022 | 09/29/2022 | $0.730 | 4.45% | 4.63% | $63.07 |
| 06/14/2022 | 06/29/2022 | $0.730 | 4.98% | 4.67% | $62.48 |
| 03/14/2022 | 03/30/2022 | $0.730 | 4.92% | 4.89% | $59.66 |
| 12/14/2021 | 12/30/2021 | $0.710 | 4.03% | 3.87% | $73.36 |
| 09/14/2021 | 09/29/2021 | $0.710 | 3.99% | 4% | $70.94 |
| 06/14/2021 | 06/29/2021 | $0.710 | 4.08% | 4.18% | $67.93 |
| 03/12/2021 | 03/30/2021 | $0.710 | 4.47% | 4.34% | $65.50 |
| 12/14/2020 | 12/30/2020 | $0.680 | 4.55% | 4.8% | $56.65 |
| 09/14/2020 | 09/29/2020 | $0.680 | 4.02% | 4.38% | $62.10 |
| 06/11/2020 | 06/29/2020 | $0.680 | 3.6% | 3.65% | $74.56 |
| 03/12/2020 | 03/30/2020 | $0.680 | 3.75% | 3.58% | $75.93 |
| 12/12/2019 | 12/30/2019 | $0.630 | 3.73% | 3.88% | $64.93 |
| 09/12/2019 | 09/27/2019 | $0.630 | 3.71% | 4.01% | $62.90 |
| 06/13/2019 | 06/27/2019 | $0.630 | 3.58% | 3.76% | $67.08 |
| 03/14/2019 | 03/28/2019 | $0.630 | 3.61% | 3.96% | $63.69 |
| 12/13/2018 | 12/28/2018 | $0.570 | 3.39% | 3.68% | $61.88 |
| 09/13/2018 | 09/27/2018 | $0.570 | 3.01% | 2.98% | $76.58 |
| 06/14/2018 | 06/28/2018 | $0.570 | 3.06% | 3.24% | $70.33 |
| 03/15/2018 | 03/29/2018 | $0.570 | 2.68% | 3.02% | $75.39 |
| 12/14/2017 | 12/28/2017 | $0.520 | 2.8% | 2.87% | $72.48 |
| 09/14/2017 | 09/28/2017 | $0.520 | 2.47% | 2.57% | $80.91 |
| 06/14/2017 | 06/29/2017 | $0.520 | 3.05% | 2.94% | $70.86 |
| 03/14/2017 | 03/30/2017 | $0.520 | 2.85% | 3.08% | $67.53 |
| 12/13/2016 | 12/29/2016 | $0.470 | 2.46% | 2.61% | $72.13 |
| 09/14/2016 | 09/29/2016 | $0.470 | 2.32% | 2.41% | $77.86 |
| 06/14/2016 | 06/29/2016 | $0.470 | 2.11% | 2.29% | $82.27 |
| 03/14/2016 | 03/30/2016 | $0.430 | 1.9% | 1.87% | $91.97 |
| 12/14/2015 | 12/30/2015 | $0.430 | 1.28% | 1.68% | $102.16 |
| 09/14/2015 | 09/29/2015 | $0.430 | 0.79% | 1.79% | $96.00 |
| 06/12/2015 | 06/29/2015 | $0.430 | 0.37% | 1.49% | $115.46 |
Projected Future Returns & Dividends for GILD
Based on past 10-year performance, here are GILD growth metrics:
Share price CAGR of +3.86%
Dividend CAGR of +5.72%
Using GILD CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| GILD (DRIP) | GILD - No DRIP | |
|---|---|---|
| Current Price | $129.31 | $129.31 |
| Start Shares | 77.33 | 77.33 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 101.73 | 77.33 |
| Dividends Payment | $1.43 | $1.43 |
| Annual Dividends | $582 | $443 |
| Yield on cost | 5.82% | 4.43% |
| Share Price | $188.83 | $188.83 |
| Total Dividends | $3,816 | $3,300 |
| Final Value | $19,210 | $17,903 |
NOTE: Above numbers are our estimate based on GILD's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
[lev_ptables no_sale]Company Info
Gilead Sciences, Inc. (GILD) had its IPO on 1992-01-22, and is trader on NASDAQ stock exchange.
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
GILD website: https://www.gilead.com
